Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0001179110-18-014316

Options or other derivatives

  • VP, Clinical&Translational Sc acquired 14,900 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
DeVinney Erick Wayne VP, Clinical&Translational Sc 2018-12-27 Grant or award · Employee Stock Option (right to purchase) +11,900 11,900 D
DeVinney Erick Wayne VP, Clinical&Translational Sc 2018-12-27 Grant or award · Restricted Stock Units +3,000 3,000 D
Loading xslF345X03/edgar.xml…